Evidence map›Paper›PMID 34940083›Full record

ArticleCurrent oncology (Toronto, Ont.)2021

Feasibility on the Use of Radiomics Features of 11[C]-MET PET/CT in Central Nervous System Tumours: Preliminary Results on Potential Grading Discrimination Using a Machine Learning Model.

Giorgio Russo, Alessandro Stefano, Pierpaolo Alongi, Albert Comelli, Barbara Catalfamo, Cristina Mantarro, Costanza Longo, Roberto Altieri, Francesco Certo, Sebastiano Cosentino and 4 more

Open access · goldAbstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Impact of [Annals of nuclear medicine · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Giorgio RussoInstitute of Molecular Bioimaging and Physiology, National Research Council (CNR), 90015 Cefalù, Italy.ORCID 0000-0003-1493-1087
Alessandro StefanoInstitute of Molecular Bioimaging and Physiology, National Research Council (CNR), 90015 Cefalù, Italy.ORCID 0000-0002-7189-1731
Pierpaolo AlongiNuclear Medicine Unit, Fondazione Istituto G. Giglio, 90015 Cefalù, Italy.ORCID 0000-0002-8397-1640
Albert ComelliInstitute of Molecular Bioimaging and Physiology, National Research Council (CNR), 90015 Cefalù, Italy.ORCID 0000-0002-9290-6103
Barbara CatalfamoNuclear Medicine Unit, Fondazione Istituto G. Giglio, 90015 Cefalù, Italy.
Cristina MantarroNuclear Medicine Unit, Fondazione Istituto G. Giglio, 90015 Cefalù, Italy.
Costanza LongoNuclear Medicine Unit, Fondazione Istituto G. Giglio, 90015 Cefalù, Italy.
Roberto AltieriNeurosurgical Unit, AOU Policlinico "G. Rodolico-San Marco", University of Catania, 95123 Catania, Italy.ORCID 0000-0003-2671-4944
Francesco CertoNeurosurgical Unit, AOU Policlinico "G. Rodolico-San Marco", University of Catania, 95123 Catania, Italy.
Sebastiano CosentinoNuclear Medicine Department, Cannizzaro Hospital, 95123 Catania, Italy.
Maria Gabriella SabiniNuclear Medicine Department, Cannizzaro Hospital, 95123 Catania, Italy.
Selene RichiusaInstitute of Molecular Bioimaging and Physiology, National Research Council (CNR), 90015 Cefalù, Italy.ORCID 0000-0003-2540-5568
Giuseppe Maria Vincenzo BarbagalloNeurosurgical Unit, AOU Policlinico "G. Rodolico-San Marco", University of Catania, 95123 Catania, Italy.
Massimo IppolitoNuclear Medicine Department, Cannizzaro Hospital, 95123 Catania, Italy.
Institute of Molecular Bioimaging and Physiology · ITOspedale Cannizzaro · ITUniversity of Catania · ITFondazione Istituto G. Giglio di Cefalù · ITUniversity of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimNowadays, Machine Learning (ML) algorithms have demonstrated remarkable progress in image-recognition tasks and could be useful for the new concept of precision medicine in order to help physicians in the choice of therapeutic strategies for brain tumours. Previous data suggest that, in the central nervous system (CNS) tumours, amino acid PET may more accurately demarcate the active disease than paramagnetic enhanced MRI, which is currently the standard method of evaluation in brain tumours and helps in the assessment of disease grading, as a fundamental basis for proper clinical patient management. The aim of this study is to evaluate the feasibility of ML on 11[C]-MET PET/CT scan images and to propose a radiomics workflow using a machine-learning method to create a predictive model capable of discriminating between low-grade and high-grade CNS tumours. MATERIALS AND

methodsIn this retrospective study, fifty-six patients affected by a primary brain tumour who underwent 11[C]-MET PET/CT were selected from January 2016 to December 2019. Pathological examination was available in all patients to confirm the diagnosis and grading of disease. PET/CT acquisition was performed after 10 min from the administration of 11C-Methionine (401-610 MBq) for a time acquisition of 15 min. 11[C]-MET PET/CT images were acquired using two scanners (24 patients on a Siemens scan and 32 patients on a GE scan). Then, LIFEx software was used to delineate brain tumours using two different semi-automatic and user-independent segmentation approaches and to extract 44 radiomics features for each segmentation. A novel mixed descriptive-inferential sequential approach was used to identify a subset of relevant features that correlate with the grading of disease confirmed by pathological examination and clinical outcome. Finally, a machine learning model based on discriminant analysis was used in the evaluation of grading prediction (low grade CNS vs. high-grade CNS) of 11[C]-MET PET/CT.

resultsThe proposed machine learning model based on (i) two semi-automatic and user-independent segmentation processes, (ii) an innovative feature selection and reduction process, and (iii) the discriminant analysis, showed good performance in the prediction of tumour grade when the volumetric segmentation was used for feature extraction. In this case, the proposed model obtained an accuracy of ~85% (AUC ~79%) in the subgroup of patients who underwent Siemens tomography scans, of 80.51% (AUC 65.73%) in patients who underwent GE tomography scans, and of 70.31% (AUC 64.13%) in the whole patients' dataset (Siemens and GE scans).

conclusionsThis preliminary study on the use of an ML model demonstrated to be feasible and able to select radiomics features of 11[C]-MET PET with potential value in prediction of grading of disease. Further studies are needed to improve radiomics algorithms to personalize predictive and prognostic models and potentially support the medical decision process.

Indexed as

Brain NeoplasmsPositron Emission Tomography Computed TomographyFeasibility StudiesHumansMachine LearningRetrospective Studiesbrain tumoursmachine learningnuclear medicinepositron emission tomography computed tomographyradiomics

Identifiers

PMID34940083
PMCPMC8700249
OpenAlexW4200133544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.